Article

The Japan Times on 2017-10-19 10:53

DeepMind's superpowerful AI sets its sights on drug discovery

DeepMind, the London-based artificial intelligence company owned by Alphabet Inc., is planning to let its software learn how to fold proteins, an important

Related news

THow AI will revolutionise drug discovery and beyond theboar.org
Switzerland , Monte-Carlo , Sedol , China , Seoul
BDeepMind's AI agent MuZero could turbocharge YouTube bbc.co.uk
Alphabet Dives Further Into AI-Driven Drug Discovery jdsupra.com
Dives
DeepMind's AI is an Atari gaming pro now wired.co.uk
Alphabet is launching a company that uses AI for drug discovery The Verge
AI: From Drug Discovery To Robotics Forbes
French AI biotech startup Owkin gets an $80-million shot from Bristol Myers Squibb to accelerate drug discovery tech.eu
Europe , France
LabGenius raises $10M to use AI for protein drug discovery TechCrunch
The Future Is Now: How AI Is Leading Drug Discovery cascadebusnews.com
Cambridge
IGoogle DeepMind unveils next-gen AI model for drug discovery invezz.com
Patentability and predictability in AI-assisted drug discovery jdsupra.com
Google DeepMind's AI is now playing Starcraft II wired.co.uk
Google DeepMind's AI can mimic realistic human speech engadget
China , United Kingdom
How DeepMind's biggest AI project is fixing bad Android batteries wired.co.uk
DeepMind's AI helps confine plasma for nuclear fusion research newatlas.com
Switzerland
Google I/O 2024 Sets Its Sights On Education With New AI LearnLM Forbes
New Zealand
CBacked by Google, a Chinese AI-powered smartwatch sets its sights on the US cnbc.com
Asia , China
Already a leader in AI, Quebec sets its sights on quantum computing CBC
China , Sherbrooke , Bromont , Canada , Montreal
Iktos raises €15.5 million Series A round for AI drug discovery service tech.eu
France
Alphabet lets AI take the lead role in new drug discovery startup newatlas.com